Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06742801 · ClinicalTrials.gov registry record · NA

Onyx™ Liquid Embolic IDE Clinical Study

A NA study of Trauma and Hemorrhage, sponsored by Medtronic Endovascular.

Recruiting
Registry status
NA
Development phase
119
Enrollment target
14
Study locations

NCT06742801 is a NA study of Trauma and Hemorrhage that is actively recruiting participants, run by Medtronic Endovascular. The registered enrollment target is 119 participants, below the 305-participant average among 56 other Trauma trials with a reported enrollment target (61% lower). The trial reports 14 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06742801, a NA study of Trauma and Hemorrhage, is actively recruiting participants, sponsored by Medtronic Endovascular.

RECRUITING
Registry status
NA
Development phase
119 participants
Enrollment target
14
Study locations

Study Summary

The purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the treatment of subjects with active arterial bleeding in the peripheral vasculature outside of the heart and brain.

Conditions Studied

Trauma Hemorrhage Ulcer GI Bleed Peripheral Arterial Hemorrhage

Interventions

  • DEVICE Onyx™ Liquid Embolic System

Study Locations (14)

California

  • University of California, Irvine - Irvine
  • Stanford Medical Center - Palo Alto

New York

  • Albany Medical Center - Albany
  • The Mount Sinai - New York

Texas

  • Univ Of Texas Southwestern - Dallas
  • The University of Texas Health Science Center at Houston - Houston

Arizona

  • Mayo Clinic - Phoenix

Colorado

  • UCHealth University of Colorado Hospital - Aurora

Connecticut

  • Yale New Haven - New Haven

Iowa

  • University of Iowa Hospitals and Clinics - Iowa City

Massachusetts

  • Masschusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2025-05-09
Est. Completion 2026-12
Phase NA

Sponsor

Medtronic Endovascular

25 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06742801

The ClinicalTrials.gov registry entry for NCT06742801 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 305-participant average among 56 other Trauma trials with a reported enrollment target (61% lower). The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Trauma appearing as the primary indexed condition, and to 1 intervention - of which Onyx™ Liquid Embolic System is the first listed.

NCT06742801 reports 14 study locations spanning 11 distinct geographic areas - top geographies include California, New York, Texas.

Frequently Asked Questions

What is clinical trial NCT06742801 about?

NCT06742801 is a clinical study titled "Onyx™ Liquid Embolic IDE Clinical Study". The purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the treatment of subjects with active arterial bleeding in the peripheral vasculature outside of the heart and brain.

What is the current status of trial NCT06742801?

This trial is currently recruiting. It is a NA study. The enrollment target is 119 participants. The study started on 2025-05-09. Estimated completion is 2026-12.

What conditions does trial NCT06742801 study?

This clinical trial studies the following conditions: Trauma, Hemorrhage, Ulcer, GI Bleed, Peripheral Arterial Hemorrhage.

What interventions are being tested in trial NCT06742801?

The interventions under investigation include: Onyx™ Liquid Embolic System (DEVICE).

Who is sponsoring clinical trial NCT06742801?

This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06742801 being conducted?

This trial has 14 study locations across Arizona, California, Colorado, Connecticut, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Trauma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Trauma

All registered trials for this condition

Hemorrhage

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.